Tislelizumab, a monoclonal antibody with a high binding affinity for the PD-1 receptor, minimizes the binding of the FC-γ receptor to macrophages, thereby eliminating antibody-dependent phagocytosis, a T-cell clearance mechanism that combats potential drug resistance in PD-1 studies. Tislelizumab may be used in studies of advanced squamous non-small cell lung cancer.
- Size: 1mg
- Purity: ≥95%
- Storage: Store at -20℃, 2 years.
- Brand: Saint Michael
- Catalogue No.: IT7230-1mg
For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.
Write Your Own Review